Nanotechnology for Alzheimer Disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Alzheimer Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.2174/1567205014666170203125008PMID 28164767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current opinion in Alzheimer's disease therapy by nanotechnology-based approaches

  2017cited by this paper
• Synopsis on Managment Strategies for Neurodegenerative Disorders: Challenges from Bench to Bedside in Successful Drug Discovery and Development.

  2017cited by this paper
• Recent Updates on the Dynamic Association Between Oxidative Stress and Neurodegenerative Disorders.

  2016cited by this paper
• Linkage of Stress with Neuromuscular Disorders.

  2016cited by this paper
• Applications of Nanotechnology in Diagnostics and Therapeutics of Alzheimer's and Parkinson's Disease.

  2015cited by this paper
• The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy.

  2015cited by this paper
• Nanoparticles as Alternative Strategies for Drug Delivery to the Alzheimer Brain: Electron Microscopy Ultrastructural Analysis.

  2015cited by this paper
• An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy.

  2015cited by this paper
• Protection after stroke: cellular effectors of neurovascular unit integrity

  2014cited by this paper
• Protein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitus.

  2014cited by this paper
• Proteomics approaches to understand linkage between Alzheimer's disease and type 2 diabetes mellitus.

  2014cited by this paper
• Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease.

  2014cited by this paper
• Therapeutic Interventions for the Suppression of Alzheimer's Disease: Quest for a Remedy.

  2014cited by this paper
• Application of Proteomic Tools in Modern Nanotechnological Approaches Towards Effective Management of Neurodegenerative Disorders.

  2014cited by this paper
• Role of nanomedicines in delivery of anti-acetylcholinesterase compounds to the brain in Alzheimer's disease.

  2014cited by this paper
• Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease

  2014cited by this paper
• A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.

  2013cited by this paper
• Gold nanoparticles as amyloid-like fibrillogenesis inhibitors.

  2013cited by this paper
• Dynamic Study of Blood–Brain Barrier Closure after its Disruption using Ultrasound: A Quantitative Analysis

  2012cited by this paper
• Novel Ocimumoside A and B as anti-stress agents: modulation of brain monoamines and antioxidant systems in chronic unpredictable stress model in rats.

  2012cited by this paper
• Molecular interaction of proteins and peptides with nanoparticles.

  2012cited by this paper
• Cellular and molecular mechanisms of antioxidants in Parkinson's disease

  2012cited by this paper
• Mitochondrial functions in astrocytes: neuroprotective implications from oxidative damage by rotenone.

  2012cited by this paper
• Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging.

  2012cited by this paper
• Brain Region Specific Monoamine and Oxidative Changes During Restraint Stress

  2012cited by this paper
• Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound.

  2012cited by this paper
• Nanotechnology-based approaches in anticancer research

  2012cited by this paper
• Effects of natural antioxidants in neurodegenerative disease

  2012cited by this paper
• Astrocytic-neuronal crosstalk: implications for neuroprotection from brain injury.

  2011cited by this paper
• Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency.

  2011cited by this paper
• Long-circulating poly(ethylene glycol)-grafted gelatin nanoparticles customized for intracellular delivery of noscapine: preparation, in-vitro characterization, structure elucidation, pharmacokinetics, and cytotoxicity analyses

  2011cited by this paper
• Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues.

  2011cited by this paper
• Graphene for controlled and accelerated osteogenic differentiation of human mesenchymal stem cells.

  2011cited by this paper
• Surface engineering of quantum dots for in vivo imaging

  2010cited by this paper
• Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.

  2010cited by this paper
• Inhibition of beta 1-40 amyloid fibrillation with N-acetyl-L-cysteine capped quantum dots.

  2010cited by this paper
• Pharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer disease.

  2010cited by this paper
• Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.

  2010cited by this paper
• Nanotechnology, nanotoxicology, and neuroscience.

  2009cited by this paper
• Challenges Associated with Metal Chelation Therapy in Alzheimer's Disease

  2009cited by this paper
• Copper and Zinc Binding to Amyloid‐β: Coordination, Dynamics, Aggregation, Reactivity and Metal‐Ion Transfer

  2009cited by this paper
• Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide.

  2008cited by this paper
• The effect of curcumin (turmeric) on Alzheimer's disease: An overview

  2008cited by this paper
• Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy

  2008cited by this paper
• Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.

  2008cited by this paper
• Medicinal applications of fullerenes

  2007cited by this paper
• Neural Stem Cells Improve Memory in an Inducible Mouse Model of Neuronal Loss

  2007cited by this paper
• Forecasting the global burden of Alzheimer's disease

  2007cited by this paper
• Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

  2007cited by this paper
• Nanoparticle-mediated local and remote manipulation of protein aggregation.

  2006cited by this paper
• Microfluidic culture platform for neuroscience research

  2006cited by this paper
• Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

  2006cited by this paper
• Optimization of a two-step desolvation method for preparing gelatin nanoparticles and cell uptake studies in 143B osteosarcoma cancer cells.

  2006cited by this paper
• PEGylated phospholipid nanomicelles interact with beta-amyloid((1-42)) and mitigate its beta-sheet formation, aggregation and neurotoxicity in vitro.

  2006cited by this paper
• Nanoscience enables ultrasensitive detection of Alzheimer's biomarker.

  2005cited by this paper
• Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease.

  2005cited by this paper
• Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor.

  2005cited by this paper
• Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles.

  2005cited by this paper
• Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation.

  2005cited by this paper
• Through metal binding, curcumin protects against lead- and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain.

  2004cited by this paper
• Probing the Cytotoxicity Of Semiconductor Quantum Dots.

  2004cited by this paper
• Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology

  2004cited by this paper
• Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts.

  2004cited by this paper
• Selective Differentiation of Neural Progenitor Cells by High-Epitope Density Nanofibers

  2004cited by this paper
• Biodistribution and Targeting Potential of Poly(ethylene glycol)-modified Gelatin Nanoparticles in Subcutaneous Murine Tumor Model

  2004cited by this paper
• Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Aβ peptides

  2004cited by this paper
• Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models

  2004cited by this paper
• Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins

  2003cited by this paper
• Long-Circulating Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles for Intracellular Delivery

  2002cited by this paper
• Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier

  2002cited by this paper
• Luminescent quantum dots for multiplexed biological detection and imaging.

  2002cited by this paper
• Grafted neural stem cells develop into functional pyramidal neurons and integrate into host cortical circuitry

  2002cited by this paper
• Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease

  2002cited by this paper
• Blockage of amyloid beta peptide-induced cytosolic free calcium by fullerenol-1, carboxylate C60 in PC12 cells.

  2000cited by this paper
• Copper, iron and zinc in Alzheimer's disease senile plaques.

  1998cited by this paper
• DNA-polycation nanospheres as non-viral gene delivery vehicles.

  1998cited by this paper
• Zinc-induced Alzheimer’s Aβ1–40 Aggregation Is Mediated by Conformational Factors*

  1997cited by this paper
• Iron accumulation in Alzheimer disease is a source of redox-generated free radicals.

  1997cited by this paper
• Carboxyfullerenes as neuroprotective agents.

  1997cited by this paper
• Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons.

  1996cited by this paper
• Rapid induction of Alzheimer A beta amyloid formation by zinc.

  1994cited by this paper
• Radical Reactions of C60

  1991cited by this paper

• A comprehensive approach to Alzheimer's Disease: Exploring Nanotechnology, treatment Innovations, and sex differences.

  2025cites this paper
• Phospho-tau 181 is enhanced in saliva and plasma of edentulous patients: a first sign of dementia?

  2025cites this paper
• Therapeutic and clinical potential of thiolutin microneedles on Alzheimer's disease mitigation.

  2025cites this paper
• Antiglycating activity of biomimetically synthesized magnetic copper ferrite nanoparticles: inhibition of methylglyoxal-derived AGEs

  2025cites this paper
• Treating Alzheimer's Disease Using Nanoparticle-Mediated Drug Delivery Strategies/Systems.

  2024cites this paper
• Innovative Approaches to Alzheimer's Therapy: Harnessing the Power of Heterocycles, Oxidative Stress Management, and Nanomaterial Drug Delivery System.

  2024cites this paper
• Evaluation and Comparison of Fullerene (C60) Aqueous Suspension Administration Effects with Memantine HCL in Rat Model of Alzheimer’s Disease Considering Behavioral Patterns and Spatial Memory

  2024cites this paper
• Development and Evaluation of Solid Lipid Nanoparticles for the Clearance of Aβ in Alzheimer’s Disease

  2023cites this paper
• Potential Neuroprotective Strategies using Smart Drug Delivery Systems for Alzheimer's Disease.

  2023cites this paper
• In-silico tuning of the nano-bio interface by molecular dynamics method: Amyloid beta targeting with two-dimensional metal-organic frameworks

  2023cites this paper
• Nanomedicine

  2023cites this paper
• Water-Soluble, Alanine-Modified Fullerene C60 Promotes the Proliferation and Neuronal Differentiation of Neural Stem Cells

  2022cites this paper
• Multiple approaches for the management of Alzheimer disease: Natural compounds, FDA approved drugs, and nanotechnology interventions.

  2022cites this paper
• Graphene as the basis of biological sensors for the diagnosis of neurodegenerative dementia

  2022cites this paper
• Fluorescence Resonance Energy Transfer-Based Aptasensor Made of Carbon-Based Nanomaterials for Detecting Lactoferrin at Low Concentrations

  2022cites this paper
• Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases.

  2022cites this paper
• Insights for Alzheimer's disease pharmacotherapy and current clinical trials.

  2022cites this paper
• Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders.

  2022cites this paper
• Fullerenol protects cornea from ultraviolet B exposure

  2022cites this paper
• Blood–nanomaterials interactions

  2022cites this paper
• Acetylcholine esterase inhibitory activity of green synthesized nanosilver by naphthopyrones isolated from marine-derived Aspergillus niger

  2021cites this paper
• Nanomedicine: A Promising Way to Manage Alzheimer’s Disease

  2021cites this paper
• Health Science Community Will Miss This Bright and Uniting Star: In Memory of Professor Gjumrakch Aliev, M.D, Ph.D.

  2021cites this paper
• The Design of Abnormal Microenvironment Responsive MRI Nanoprobe and Its Application

  2021cites this paper
• Strategic approaches to target the enzymes using natural compounds for the management of Alzheimer's disease: A review.

  2021cites this paper
• Synthesis, Computational Pharmacokinetics Report, Conceptual DFT-Based Calculations and Anti-Acetylcholinesterase Activity of Hydroxyapatite Nanoparticles Derived From Acorus Calamus Plant Extract

  2021cites this paper
• Nanomaterials for neurodegenerative diseases: Molecular mechanisms guided design and applications

  2021cites this paper
• Nanomaterials for Point of Care Disease Detection

  2020cites this paper
• Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer’s disease: a meta-analytic review on potential mechanisms

  2020cites this paper
• The structure and function of α, β and γ-Secretase as therapeutic target enzymes into the development of Alzheimer's disease: A review.

  2020cites this paper
• Recent Progress of Nanomedicine in the Treatment of Central Nervous System Diseases

  2020cites this paper
• Preparation, Optimization, and Evaluation of Methoxy Poly (ethylene glycol)-co-Poly (ε-caprolactone) Nanoparticles Loaded by Rivastigmine for Brain Delivery.

  2020cites this paper
• Increasing the versatility of an ex vivo model in nanosafety studies and fibrosis

  2020cites this paper
• Alzheimer’s disease: review of current nanotechnological therapeutic strategies

  2020cites this paper
• The influence of nanoparticulate drug delivery systems in drug therapy

  2020cites this paper
• Self- assembled lactoferrin-conjugated linoleic acid micelles as an orally active targeted nanoplatform for Alzheimer's disease.

  2020cites this paper
• Role of Withaferin A as a Neuroprotectant against Beta Amyloid Induced Toxicity and associated mechanism

  2019cites this paper
• Dependence of fullerene aggregation on lipid saturation due to a balance between entropy and enthalpy

  2019cites this paper
• Fullerene-based delivery systems.

  2019cites this paper
• Potential of Tribological Properties of Metal Nanomaterials in Biomedical Applications.

  2019cites this paper
• Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems.

  2019cites this paper
• Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics

  2019cites this paper
• Neurotheranostics as personalized medicines.

  2019cites this paper
• Effects of Gold Nanospheres and Nanocubes on Amyloid-β Peptide Fibrillation.

  2019cites this paper
• Enhancement of Declarative Memory: From Genetic Regulation to Non-invasive Stimulation

  2018cites this paper
• Exploring Nanotechnology Applications in Medicine

  2018cites this paper
• Inhibiting Effect of Zinc Oxide Nanoparticles on Advanced Glycation Products and Oxidative Modifications: a Potential Tool to Counteract Oxidative Stress in Neurodegenerative Diseases

  2018cites this paper
• The Design, Fabrication, and Characterization of Nanoparticle-Protein Interactions for Theranostic Applications

  2017cites this paper
• Editorial: Alzheimer's Disease: From Molecular Mechanisms to Psychobiological Perspectives.

  2017cites this paper
• Digital Commons @ University of Digital Commons @ University of South Florida South Florida

  year unknowncites this paper
• Applications of Nanotechnology in Ayurveda: A review

  year unknowncites this paper